Linked Life Data

15948474

Source:http://linkedlifedata.com/resource/pubmed/id/15948474

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-6-13
pubmed:abstractText
The traditional surgical treatment of benign bone tumors has been curettage and autologous bone graft or marginal resection of expendable bones. These procedures are associated with good results in most patients and should be considered the standard against which newer treatments are compared. Recently, however, surgeons have been evaluating the results of treatments using limited surgical approaches, including percutaneous treatments, alternatives to autograft bone, and thermal or cytotoxic adjuvant therapies. The goal has been to improve patient outcomes by decreasing perioperative morbidity and enhancing surgical efficiency. This process has been facilitated by the availability of multiple bone grafting materials and substitutes, the use of cross-sectional imaging, and technology such as that used with radiofrequency ablation. Techniques using these therapies in two benign bone tumor models are described. The use of percutaneous radiofrequency ablation, now used for both benign and malignant disease, is reviewed as a surgical alternative for osteoid osteoma. The role of adjuvant therapies such as liquid nitrogen and phenol, as well as the indications for resection, are described in the management of giant cell tumors of bone.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0065-6895
pubmed:author
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
497-503
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Beyond bone grafting: techniques in the surgical management of benign bone tumors.
pubmed:affiliation
Orthopaedic Surgery, University of Florida, Gainsville, USA.
pubmed:publicationType
Journal Article, Review